HEALTH
Cognitive Decline Reduced by 27%: New Alzheimer’s Drug Passes Phase III Clinical Trials
Lecanemab reaches primary clinical endpoint and all secondary clinical endpoints in the…
Wake Up to the Myth of Melatonin as a Sleep Aid
A large amount of clinical research data shows that melatonin does not have a significant…
Launched Amid Controversy, New ALS Drug Approved by the FDA
More than 200,000 patients worldwide are urgently awaiting the emergence of new drugs.
Sixty Years Later, the First Drug with a New Mechanism is Approved, Potentially Changing the Paradigm of Antidepressant Treatment
Axsome is expected to be the first to launch Auvelity in the United States in the fourth…
By Uncovering the Mechanism of Anti-Anxiety Medications Impairing Cognition, Can We Develop Drugs with Fewer Side Effects?
How does long-term use of anti-anxiety medications lead to cognitive impairments?
The Enigma of Alzheimer’s Drug Development: Why is the Failure Rate as High as 99.6%?
Why has Alzheimer's disease become the 'graveyard of new drug development'?
INDUSTRY
Fighting Aging with Games: Will the Cognitive Training Market Succeed?
Are cognitive training programs like video games really effective?
Will Oxytocin Give Birth to a New Market for Stress Relief?
Will oxytocin have new therapeutic prospects?
Can Profit-Driven Companies Find a Cure for Autism?
Applied Behavior Analysis is causing increasing distress for many families.
Continuous Controversies in Anti-Alzheimer’s Drug Research: Does Alleged Fraud Spell Doom?
The trials continue, as do the doubts.